Guangzhou Newlife New Material Valuation

Is 301323 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301323 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301323 (CN¥37) is trading above our estimate of fair value (CN¥4.64)

Significantly Below Fair Value: 301323 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301323?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 301323. This is calculated by dividing 301323's market cap by their current preferred multiple.
What is 301323's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

301323 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.5x
Enterprise Value/EBITDA	21.1x
PEG Ratio	1.1x

Price to Earnings Ratio vs Peers

How does 301323's PE Ratio compare to its peers?

The above table shows the PE ratio for 301323 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	76.2x
002666 Guangdong Delian Group	52.4x	n/a	CN¥3.7b
688269 Kaili Catalyst & New MaterialsLtd	47.7x	46.6%	CN¥3.8b
688733 Anhui Estone Materials TechnologyLtd	178.3x	62.7%	CN¥4.3b
688267 China Catalyst Holding	26.4x	20.2%	CN¥3.9b
301323 Guangzhou Newlife New Material	27.3x	24.1%	CN¥3.8b

Price-To-Earnings vs Peers: 301323 is good value based on its Price-To-Earnings Ratio (27.3x) compared to the peer average (76.2x).

Price to Earnings Ratio vs Industry

How does 301323's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	39.5%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	39.5%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 301323 is good value based on its Price-To-Earnings Ratio (27.3x) compared to the CN Chemicals industry average (38x).

Price to Earnings Ratio vs Fair Ratio

What is 301323's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301323 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	27.3x
Fair PE Ratio	21.4x

Price-To-Earnings vs Fair Ratio: 301323 is expensive based on its Price-To-Earnings Ratio (27.3x) compared to the estimated Fair Price-To-Earnings Ratio (21.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.